01—Abstract
Summary
Summary of the 8-K filed July 16, 2025. Cited figures are marked; the original filing is the authoritative source.
On July 16, 2025, SLB completed its all-stock acquisition of ChampionX Corporation under the Merger Agreement dated April 2, 2024.
Each ChampionX share was exchanged for 0.735 shares of SLB common stock, with cash paid in lieu of fractional shares. Former ChampionX shareholders now own approximately 9%a of SLB's outstanding common stock. The Merger Shares were registered on SLB's Form S-4 (File No. 333-278976), which the SEC declared effective on April 29, 2024.
Strategically, SLB frames the deal as a move into production and recovery, a segment it describes as less cyclical and growing. The acquisition adds ChampionX's production chemicals, artificial lift, digital, and emissions technologies, along with its North American customer relationships. Management expects annual pretax synergies of approximately $400 millionb within three years of closing, through both revenue growth and cost savings.
SLB also reiterated that it remains on track to return $4 billionc to shareholders in 2025. For investors, the key considerations are dilution from the roughly 9% share issuance, the execution risk of integrating ChampionX and realizing the $400 million synergy target, and whether the production-focused business supports the capital-light, returns-focused strategy management has outlined. The filing itself provides no updated financial figures for the combined company, so investors should refer to SLB's periodic reports for pro forma results.
02—Key points
Key Highlights
- Closed the all-stock acquisition of ChampionX Corporation on July 16, 2025, with each ChampionX share exchanged for 0.735 SLB shares.
- Former ChampionX shareholders now own approximately 9% of SLB's outstanding common stock, implying meaningful share dilution for existing holders.
- Management expects approximately $400 million in annual pretax synergies within three years of closing, from revenue growth and cost savings.
- ChampionX equity awards were converted into SLB awards: options and RSUs were rolled over on the Exchange Ratio, while in-the-money SARs and dividend equivalents were settled in cash.
- SLB reaffirmed its plan to return $4 billion to shareholders in 2025 despite the acquisition.
- The acquisition expands SLB into production chemicals, artificial lift, and emissions technologies, which management describes as a less cyclical, growing market.
- The Merger Shares were registered on Form S-4 (File No. 333-278976), declared effective by the SEC on April 29, 2024.
03—Questions
Frequently Asked Questions
How much SLB stock did ChampionX shareholders receive?
Each ChampionX common share was exchanged for 0.735 shares of SLB common stock, with cash paid in lieu of any fractional shares. Former ChampionX holders now own about 9% of SLB's outstanding common stock.
What happened to ChampionX equity awards?
Stock options and restricted stock units, restricted stock awards, and performance shares converted into SLB equivalents based on the Exchange Ratio. Deferred stock units became rights to receive SLB shares. In-the-money stock appreciation rights were paid in cash, out-of-the-money SARs were cancelled, and accrued dividend equivalents were paid in cash.
What synergies does SLB expect from the deal?
SLB expects annual pretax synergies of approximately $400 million within the first three years after closing, from a combination of revenue growth and cost savings.
Does the acquisition affect SLB's shareholder return plans?
No change was announced. SLB stated it remains on track to return $4 billion to shareholders in 2025.
Where can I find the full terms of the merger?
The Merger Agreement was filed as Exhibit 2 to SLB's Form 8-K/A on April 3, 2024, and is incorporated by reference. Some schedules and exhibits were omitted under Regulation S-K Item 601(b)(2), and SLB has agreed to furnish them to the SEC on request.
04—Continue